[In-vitro potentiation of the anti-tuberculous effects of rifampicin and ethionamide by 4,4-diamino-diphenylsulphone (author's transl)].
D003622:Dapsone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005000:Ethionamide / Q000494:pharmacology*; D066298:In Vitro Techniques; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology*
D003622:Dapsone; D005000:Ethionamide; D012293:Rifampin
Potenzierung der Wirkung von Rifampicin und Ethionamid durch das gegen M. tuberculosis unwirksame 4,4-Diamino-Diphenylsulfon (DDS) in vitro